BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33578515)

  • 1. High Hepatic leukemia factor expression indicates a favorable survival in glioma patients.
    Liu Q; Ge H; Liu P; Li Y
    Medicine (Baltimore); 2021 Feb; 100(6):e23980. PubMed ID: 33578515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.
    Chen S; Wang Y; Ni C; Meng G; Sheng X
    Biomed Pharmacother; 2016 Oct; 83():898-904. PubMed ID: 27522003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network model of a cooperative genetic landscape in brain tumors.
    Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
    JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
    Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T
    J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
    Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
    Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
    Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma.
    Zhang JX; Han L; Bao ZS; Wang YY; Chen LY; Yan W; Yu SZ; Pu PY; Liu N; You YP; Jiang T; Kang CS;
    Neuro Oncol; 2013 Dec; 15(12):1595-603. PubMed ID: 24203894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
    Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
    Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
    Shen S; Yao Y
    Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
    Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.